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Abstract:  Oxidative  stress  is  implicated  in  the  pathogenesis  and/or  complications  of 
hypertension and/or diabetes mellitus. A combination of these disorders increases the risk 
of developing cardiovascular events. This study investigated the effects of streptozotocin 
(60 mg/kg; ip)-induced diabetes on blood pressure, oxidative stress and effects of honey on 
these parameters in the kidneys of streptozotocin-induced diabetic Wistar-Kyoto (WKY) 
and spontaneously hypertensive rats (SHR). Diabetic WKY and SHR were randomized 
into four groups and received distilled water (0.5 mL) and honey (1.0 g/kg) orally once 
daily for three weeks. Control SHR had reduced malondialdehyde (MDA) and increased 
systolic blood pressure (SBP), catalase (CAT) activity, and total antioxidant status (TAS). 
SBP,  activities  of  glutathione  peroxidase  (GPx)  and  glutathione  reductase  (GR)  were 
elevated while TAS was reduced in diabetic WKY. In contrast, SBP, TAS, activities of 
OPEN ACCESS Int. J. Mol. Sci. 2011, 12                       
 
 
1889 
GPx and GR were reduced in diabetic SHR. Antioxidant (honey) treatment further reduced 
SBP in  diabetic SHR  but  not  in  diabetic  WKY. It also  increased TAS,  GSH,  reduced 
glutathione (GSH)/oxidized glutathione (GSSG) ratio, activities of GPx and GR in diabetic 
SHR. These data suggest that differences in types, severity, and complications of diseases 
as well as strains may influence responses to blood pressure and oxidative stress. 
Keywords:  hypertension;  diabetes  mellitus;  streptozotocin;  spontaneously  hypertensive 
rats; antioxidant enzymes; oxidative stress; kidney; tualang honey 
 
1. Introduction 
Epidemiological studies suggest that hypertension or diabetes mellitus is a major risk factor for 
cardiovascular disease [1]. It is also known that persons with both hypertension and diabetes mellitus 
are at a higher risk of developing cardiovascular events than are individuals with either
 risk factor 
alone [2]. Similarly, in animal models, chemically induced diabetes produces more profound effects in 
spontaneously  hypertensive rats (SHR)  than it does in  normotensive strains  such as  Wistar-Kyoto 
(WKY) rats [3]. In diabetes mellitus and/or hypertension, the kidney is either a target or it plays a 
prominent role in these disorders. 
The actual mechanisms by which diabetes exacerbates hypertension still remain unclear. However, 
a number of hypotheses have been postulated to explain some of these mechanisms [4,5]. One of such 
mechanisms is the role of oxygen-derived free radicals. During atherogenesis, enhanced
 monocyte 
adherence to the endothelium, believed to be mediated
 by induced expression of adhesion molecules 
and chemotactic
 proteins, is linked to imbalances or changes in the redox or oxidative state of the 
endothelial cells [4,6]. In diabetes, hyperglycemia and/or hyperlipidemia is implicated in the increased
 
generation of reactive oxygen species from vascular cells [7,8]. This oxidative stress may trigger a 
number of oxidant-responsive
 genes that play a prominent role in monocyte-endothelial cell adhesion 
resulting  in  endothelial  dysfunction  [9–11].  Friedman  et  al.  [12]  showed  that  the  combination  of 
hypertension and diabetes mellitus is accompanied by higher oxidative stress than that observed in the 
individual disorder alone [12].  These results would suggest that combined effects of diabetes and 
hypertension might elicit more pronounced effects not only on redox or antioxidant status but also on 
their complications compared to the influence of either disease alone.  
A number of ex vivo studies have documented the antibacterial, antiproliferative, and antioxidant 
properties of Malaysian tualang honey [13–15]. This honey has been shown by us to produce glucose 
lowering  as  well  as  protective  effects  against  oxidative  stress  in  kidney  and  pancreas  in 
streptozotocin-induced diabetic Sprague-Dawley rats [16–18]. Since oxidative stress is recognized as
 a 
putative factor in the development and complications of both diabetes mellitus
 and hypertension, it 
would be interesting to explore the effects of honey in experimental animals with combined diabetic 
and  hypertensive  pathologies.  In  the  present  study,  we  have  investigated  the  effects  of 
streptozotocin-induced diabetes on blood pressure, antioxidant enzymes, markers of oxidative stress 
and the effects of tualang honey on some of these parameters in the kidneys of streptozotocin-induced 
diabetic WKY and SHR. Int. J. Mol. Sci. 2011, 12                       
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2. Results and Discussion  
2.1. Systolic Blood Pressure 
Figure 1 shows the systolic blood pressure (BP) in control and STZ-induced diabetic WKY and 
SHR. Control SHR had significantly (p < 0.001) higher systolic BP than control WKY. Systolic BP 
was significantly (p < 0.05) reduced in STZ-induced diabetic SHR while it was significantly (p < 0.01) 
increased in STZ-induced diabetic WKY compared to their corresponding control partners. Treatment 
with tualang honey further reduced significantly (p < 0.01) BP in STZ-induced diabetic SHR but not in 
STZ-induced diabetic WKY.  
2.2. Blood Glucose and Body Weight 
Figure 2 shows the blood glucose levels in control and STZ-induced diabetic WKY and SHR. 
Blood glucose concentrations were similar in the control WKY and control SHR. The blood glucose 
levels were significantly (p < 0.01) elevated in the STZ-induced diabetic WKY and SHR compared to 
the control WKY and control SHR, respectively. The blood glucose concentrations were significantly 
(p  <  0.05)  increased  in  STZ-induced  diabetic  SHR  compared  to  STZ-induced  diabetic  WKY. 
Treatment with honey significantly (p < 0.05) reduced blood glucose levels in diabetic WKY but not 
significantly in diabetic SHR.  
Figure 3 shows change in body weight in control and STZ-induced diabetic WKY and SHR at the 
end  of  the  treatment  period.  Before  commencement  of  treatment,  SHR  had  reduced  body  weight 
compared to WKY (data not shown). At the end of the treatment period, body weight was significantly 
(p < 0.01) lower in the control SHR compared to control WKY. With STZ-induced diabetes, body 
weight was significantly (p < 0.01 and p < 0.001) reduced in WKY and SHR, respectively compared to 
control  rats  of  the  same  strain.  STZ-induced  diabetic  SHR  lost  more  weight  (but  not  statistically 
significant)  than  STZ-induced  diabetic  WKY.  Treatment  of  diabetic  WKY  and  SHR  with  honey 
produced no effect on body weight.  
2.3. Antioxidant Enzymes 
Figure 4 shows the catalase (CAT) activity in control and STZ-induced diabetic WKY and SHR. 
Control  SHR  had  significantly  (p  <  0.05)  higher  CAT  activity  compared  to  control  WKY.  With  
STZ-induced diabetes, CAT activity was reduced in both WKY and SHR. The reduced CAT activity 
was  more  pronounced  in  diabetic  SHR  than  in  diabetic  WKY.  Treatment  of  diabetic  WKY  and 
diabetic SHR with honey did not restore CAT activity. Figure 5 shows the GPx activity in control and 
STZ-induced diabetic WKY and SHR. GPx activity was similar in the control WKY and control SHR. 
GPx  activity  was  significantly  (p  <  0.05)  elevated  in  diabetic  WKY  while  it  was  significantly  
(p  <  0.05)  reduced  in diabetic  SHR. Treatment  with  honey  significantly (p  <  0.05)  restored  GPx 
activity in both diabetic WKY and  diabetic SHR. Figure 6 shows that GR activity was increased 
though not significantly in diabetic WKY while it was significantly (p < 0.05) reduced in diabetic 
SHR. Treatment with honey significantly (p < 0.05) reduced GR activity in diabetic WKY while it Int. J. Mol. Sci. 2011, 12                       
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significantly (p < 0.05) increased GR activity in diabetic SHR. Activities of Superoxide Dismutase 
(SOD) and Glutathione-S-Transferase (GST) remained the same in the all the groups (data not shown). 
2.4. Markers of Oxidative Stress 
Figure 7 shows the total antioxidant status (TAS) in control and STZ-induced diabetic WKY and 
SHR.  Control  SHR  had  significantly  (p  <  0.05)  higher  TAS  than  did  control  WKY.  TAS  was 
significantly reduced  in diabetic  WKY and  diabetic  SHR (p  <  0.01 and p <  0.001,  respectively). 
Treatment with honey significantly (p < 0.01) increased TAS in diabetic SHR but not in diabetic 
WKY. Figure 8 shows the malondialdehyde (MDA) levels in control and STZ-induced diabetic WKY 
and SHR. Control SHR had significantly (p < 0.01) lower MDA levels than did control WKY. MDA 
levels were much lower (though not statistically significant) in the remaining SHR groups compared to 
corresponding WKY. Treatment with honey further reduced MDA levels but not significantly in both 
diabetic WKY and diabetic SHR. 
Figures  9  and  10  show  the  levels  of  reduced  glutathione  (GSH)  and  GSH/GSSG  (oxidized 
glutathione)  ratio  in  control  and  STZ-induced  diabetic  WKY  and  SHR.  The  levels  of  GSH  and 
GSH/GSSG ratio were similar in the control WKY and control SHR. With STZ-induced diabetes, the 
levels of GSH and GSH/GSSG ratio still remained comparable in the diabetic WKY and diabetic SHR. 
Treatment with honey increased GSH significantly (p < 0.01) in diabetic SHR but not significantly in 
diabetic WKY. Also, with honey treatment, GSH/GSSG ratio was increased significantly (p < 0.05) in 
both diabetic WKY and diabetic SHR. The levels of GSSG remained the same in all the groups (data 
not shown). 
Figure 1. Effect of honey on systolic blood pressure in streptozotocin-induced diabetic 
WKY and SHR. Each group consisted of five to seven animals. Data are expressed as 
mean ±  SEM. WKY, Wistar-Kyoto rats; SHR, spontaneously hypertensive rats; C-WKY, 
control  WKY;  C-SHR,  control  SHR;  D-WKY,  diabetic  WKY;  D-SHR,  diabetic  SHR; 
DH-WKY,  diabetic  WKY  +  honey;  DH-SHR,  diabetic  SHR  +  honey.  **  p  <  0.01, 
***p < 0.001 versus C-WKY; ‡p < 0.05 versus C-SHR; § §  p < 0.01 versus D-SHR. 
 
  ** 
 
  *** 
 
   ‡ 
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Figure  2.  Effect  of  honey  on  fasting  blood  glucose  in  streptozotocin-induced  diabetic 
WKY and SHR. Each group consisted of five to seven animals. Data are expressed as 
mean ±  SEM. WKY, Wistar-Kyoto rats; SHR, spontaneously hypertensive rats; C-WKY, 
control  WKY;  C-SHR,  control  SHR;  D-WKY,  diabetic  WKY;  D-SHR,  diabetic  SHR; 
DH-WKY, diabetic WKY + honey; DH- SHR, diabetic SHR + honey. *** p < 0.001 
versus C-WKY; † p < 0.05 versus D-WKY; ‡‡ p < 0.01 versus C-SHR. 
 
Figure 3. Effect of honey on change in body weight of streptozotocin-induced diabetic 
WKY and SHR. Each group consisted of five to seven animals. Data are expressed as 
mean ±  SEM. WKY, Wistar-Kyoto rats; SHR, spontaneously hypertensive rats; C-WKY, 
control  WKY;  C-SHR,  control  SHR;  D-WKY,  diabetic  WKY;  D-SHR,  diabetic  SHR; 
DH-WKY, diabetic WKY + honey; DH-SHR, diabetic SHR + honey. ** p < 0.01 versus 
C-WKY; ‡‡‡ p < 0.001 versus C-SHR. 
 
   † 
*** 
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Figure 4. Effect of honey on catalase activity in kidney of streptozotocin-induced diabetic 
WKY and SHR. Each group consisted of five to seven animals. Data are expressed as mean 
±  SEM. WKY, Wistar-Kyoto rats; SHR, spontaneously hypertensive rats; C-WKY, control 
WKY; C-SHR, control SHR; D-WKY, diabetic WKY; D-SHR, diabetic SHR; DH-WKY, 
diabetic WKY + honey; DH-SHR, diabetic SHR + honey. * p < 0.05 versus C-WKY;  
‡ p < 0.05 versus C-SHR. 
 
Figure  5.  Effect  of  honey  on  glutathione  peroxidase  (GPx)  activity  in  kidney  of 
streptozotocin induced diabetic WKY and SHR. Each group consisted of five to seven 
animals.  Data  are  expressed  as  mean  ±   SEM.  WKY,  Wistar-Kyoto  rats;  SHR, 
spontaneously hypertensive rats; C-WKY, control WKY; C-SHR, control SHR; D-WKY, 
diabetic  WKY;  D-SHR,  diabetic  SHR;  DH-WKY,  diabetic  WKY  +  honey;  DH-SHR, 
diabetic SHR + honey. * p < 0.05 versus C-WKY; † p < 0.05 versus D-WKY; ‡ p < 0.05 
versus C-SHR; §  p < 0.05 versus D-SHR. 
 
    * 
 
  ‡ 
    * 
    † 
  ‡ 
 §  
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Figure  6.  Effect  of  honey  on  glutathione  reductase  (GR)  activity  in  kidney  of 
streptozotocin-induced diabetic WKY and SHR. Each group consisted of five to seven 
animals.  Data  are  expressed  as  mean  ±   SEM.  WKY,  Wistar-Kyoto  rats;  SHR, 
spontaneously hypertensive rats; C-WKY, control WKY; C-SHR, control SHR; D-WKY, 
diabetic  WKY;  D-SHR,  diabetic  SHR;  DH-WKY,  diabetic  WKY  +  honey;  DH-SHR, 
diabetic SHR + honey. † p < 0.05 versus D-WKY; ‡ p < 0.05 versus C-SHR; §  p < 0.05 
versus D-SHR. 
 
Figure 7. Effect of honey on total antioxidant status (TAS) in kidney of streptozotocin 
induced diabetic WKY and SHR. Each group consisted of five to seven animals. Data are 
expressed as mean ±  SEM. WKY, Wistar-Kyoto rats; SHR, spontaneously hypertensive 
rats;  C-WKY,  control  WKY;  C-SHR,  control  SHR;  D-WKY,  diabetic  WKY;  D-SHR, 
diabetic  SHR;  DH-WKY,  diabetic  WKY  +  honey;  DH-SHR,  diabetic  SHR  +  honey.  
* p < 0.05, ** p < 0.01 versus C-WKY; ‡‡‡ p < 0.001 versus C-SHR; § §  p < 0.01 versus 
D-SHR. 
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Figure 8. Effect of honey on malondialdehyde (MDA) in kidney of streptozotocin-induced 
diabetic WKY and SHR. Each group consisted of five to seven animals. Data are expressed 
as  mean  ±   SEM.  WKY,  Wistar-Kyoto  rats;  SHR,  spontaneously  hypertensive  rats;  
C-WKY, control WKY; C-SHR, control SHR; D-WKY, diabetic WKY; D-SHR, diabetic 
SHR; DH-WKY, diabetic WKY + honey; DH-SHR, diabetic SHR + honey. ** p < 0.01 
versus C-WKY. 
 
Figure  9.  Effect  of  honey  on  reduced  glutathione  (GSH)  in  kidney  of  streptozotocin 
induced diabetic WKY and SHR. Each group consisted of five to seven animals. Data are 
expressed as mean ±  SEM. WKY, Wistar-Kyoto rats; SHR, spontaneously hypertensive 
rats;  C-WKY,  control  WKY;  C-SHR,  control  SHR;  D-WKY,  diabetic  WKY;  D-SHR, 
diabetic  SHR;  DH-WKY,  diabetic  WKY  +  honey;  DH-SHR,  diabetic  SHR  +  honey.  
§§ p < 0.01 versus D-SHR. 
 
 
§§ 
 
  ** 
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Figure 10. Effect of honey on GSH/GSSG in kidney of streptozotocin induced diabetic 
WKY and SHR. Each group consisted of five to seven animals. Data are expressed as 
mean ±  SEM. WKY, Wistar-Kyoto rats; SHR, spontaneously hypertensive rats; C-WKY, 
control  WKY;  C-SHR,  control  SHR;  D-WKY,  diabetic  WKY;  D-SHR,  diabetic  SHR; 
DH-WKY, diabetic WKY + honey; DH-SHR, diabetic SHR + honey. † p < 0.05 versus 
D-WKY; §  p < 0.05 versus D-SHR. 
 
The use of spontaneously hypertensive rats as an animal model to study the pathogenesis and/or 
complications of hypertension is well documented [19]. Streptozotocin (STZ), an antibiotic derived 
from Streptomyces achromogenes, is a common chemical of choice for inducing animal models of 
diabetes. Its diabetogenic effect is attributed to its irreversible damage to pancreatic β-cells [20]. The 
induction  of  diabetes  in  normotensive  and  hypertensive  rats  serves  as  an  experimental  model  to 
investigate the effects of diabetes alone as well as the combined effects of diabetes and hypertension in 
rats. In this study, STZ-treated Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR) 
had significantly increased blood glucose levels compared to control WKY and SHR, respectively as 
previously reported [21]. In our preliminary results, we had observed that resistance to STZ was higher 
in WKY than in SHR while mortality was much higher in diabetic SHR than in diabetic WKY [22]. 
From our data, STZ-induced diabetes had a more profound effect on glycemia in SHR than in WKY. 
The reason for this is not quite clear. However, some studies have shown that the β-cells are selectively 
susceptible to STZ, an analog of N-acetylglucosamine (GlcNAc), because they contain higher activity 
of O-GlcNAc transferase (OGT) (OGT, the enzyme responsible for attaching O-GlcNAc to proteins) 
more than other cell types [23]. So, it is likely that OGT may be intrinsically over-expressed in SHR  
β-cells more than in WKY β-cells. There is also a possibility of increased uptake of STZ into SHR 
β-cells. Moreover, increased oxidative stress is reportedly generated in SHR compared to WKY [24]. 
Since cytotoxic effect of STZ is believed to be mediated partly through the release of nitric oxide (NO) 
and reactive oxygen species (ROS) [25,26], administration of STZ might further expose the SHR  
β-cells to increased levels of free radicals, thus resulting in increased cytotoxicity. These and other 
mechanisms which require further investigation may play a role in the increased sensitivity of SHR  
β-cells to STZ. Honey supplementation reduced hyperglycemia significantly in diabetic WKY, similar 
† 
 
   §  
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to  what  we  found  in  diabetic  Sprague-Dawley  rats  [16–18].  However,  honey  did  not  reduce 
hyperglycemia significantly in diabetic SHR. This might be due to the severity of hyperglycemia or 
diabetes  in  these  rats.  Insulin  treatment,  in  spite  of  increased  serum  insulin,  also  did  not  reduce 
hyperglycemia in diabetic SHR [21]. The significantly reduced body weight observed in control SHR 
is similar to what was reported by other researchers [21]. Our results also showed that in STZ-induced 
diabetes,  the  magnitudes  of  weight  loss  were  more  in  diabetic  SHR  than  in  diabetic  WKY.  In  
STZ-induced  diabetes,  proteolysis,  enhanced  utilization,  and  mobilization  of  lipid  in  the  skeletal 
muscles are reported to cause weight loss [27,28]. Contrary to our previous findings [16,17], it is quite 
unclear why honey treatment did not improve body weight in both diabetic WKY and SHR. 
Systolic blood pressure (BP) was significantly higher in control SHR than in control WKY similar 
to what was previously reported [29]. Increased production of superoxide anions is implicated in the 
pathogenesis of elevated blood pressure in SHR [30]. We also found that STZ-induced diabetic WKY 
had significantly elevated BP compared to control WKY. Our results are consistent with those of 
Bunag et al. [31]. They found that BP, beginning by the second week, was significantly elevated in 
STZ-treated rats and the elevated blood pressure persisted through the seventh week. Other researchers 
also  reported  similar  findings  [32].  On  the  other  hand,  there  are  reports  of  decreased  blood  
pressure [33], or  no change [34],  with  STZ-induced  diabetes.  The mechanisms  by which  diabetic 
normotensive rats become hypertensive or hypotensive still remain poorly understood. At present, it is 
uncertain  whether  hypertension  is  secondary  to  diabetes  or  STZ  causes  hypertension.  However, 
Kawashima et al. [35] showed that STZ at different doses, even the lowest dose (20 mg/kg) which did 
not have an effect on the blood glucose levels, significantly increased blood pressure. Based on their 
findings,  they  reported  that  hyperglycemia  is  not  a  prerequisite  for  induction  of  hypertension  by 
STZ [35]. In this study, honey treatment in diabetic WKY did not reduce elevated BP. This seems to 
suggest that the mechanisms of hypertension in STZ-treated WKY might be unrelated to oxidative 
stress but due to other mechanisms which need further investigation. 
With STZ-induced diabetes, BP was significantly reduced in diabetic SHR compared to control 
SHR. Also, there are conflicting reports on blood pressure in diabetic SHR. Our results are similar to 
those of Davidoff et al. [21], Rodgers [34] and Susic et al. [36] who all reported lower blood pressure 
in diabetic SHR. However, other researchers did report elevated blood pressure [32], or no change in 
blood pressure [37], in STZ-induced SHR. The hypotensive effect of diabetes in SHR is a consequence 
of reduced peripheral resistance [36]. The implications of reduced BP in diabetic SHR remain unclear. 
However, Davidoff and Rodgers [38] reported that decreased blood pressure of diabetic SHR was also 
accompanied  by  a  progressive  decline  in  heart  rate.  They  further  showed  that  insulin  treatment 
prevented  both  the  depressor  and  bradycardic  effects  of  diabetes  in  SHR.  Their  findings  seem  to 
indicate  that  reduced  blood  pressure  and  bradycardia  as  a  result  of  diabetes  in  SHR  might 
be detrimental.  
Unlike in Davidoff and Rodgers’s study [38], honey supplementation in diabetic SHR resulted in 
further reduction of BP. Our results corroborate those of Medeiros et al. [39] who reported that olive 
oil or fish oil produced further diminution of blood pressure in diabetic SHR. Olive oil and fish oil, 
like tualang honey [16–18], are reported to ameliorate oxidative stress [40,41]. In view of the fact that 
oxidative stress is implicated in the pathogenesis and/or maintenance of hypertension in SHR, the 
further reduction of BP elicited by these oils or honey might be due to their antioxidant effects. On the Int. J. Mol. Sci. 2011, 12                       
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other hand, insulin, unknown to exhibit antioxidant effect, might improve diabetes and other metabolic 
derangements  including  hyperglycemia.  These  effects  of  insulin  might  diminish  or  counteract  the 
effects of diabetes on blood pressure resulting in restoration of the BP towards that of the control SHR. 
Moreover, considering that these researchers reported hyperinsulinemia after a prolonged treatment 
period, it is possible that elevated insulin levels generated ROS contributing to the steady increments 
in blood pressure [42].  
Our data showed that the activities of GPx and GR were up-regulated in diabetic WKY whereas 
they were down-regulated in diabetic SHR. Further studies are required to clarify the reasons and also 
perhaps the implications of these disparities. However, since diabetic WKY compared to diabetic SHR 
had  moderate  levels  of  hyperglycemia,  free  radicals  generated  in  diabetic  WKY  might  be  less 
compared to those formed in diabetic SHR. As a result, the up-regulated activities of GPx and GR 
might  be  a  compensatory  mechanism  to  protect  the  kidneys  from  the  detrimental  effects  of  free 
radicals  [43].  On  the  other  hand,  considering  the  severity  of  hyperglycemia  in  diabetic  SHR,  the 
kidneys of these rats might be exposed to higher levels of oxidative stress resulting in glycation or 
inhibition of GPx and GR [44,45]. Besides, elevated blood pressure in SHR might also contribute to 
increased generation of free radicals [30]. Furthermore, there are reports that differences in sex, tissue, 
and  duration  of  diseases  influence  the  responses  of  antioxidant  enzymes  to  changes  in  redox  
status [46,47]. Therefore, in diabetic WKY and diabetic SHR, the differential responses of GPx and 
GR activities (induction or inhibition) to oxidative stress might be attributed to differences in types, 
severity,  and  combinations/complications  of  diseases  as  well  as  strains  of  animals.  We  found  a 
significantly reduced TAS and a slightly, non-significantly depressed activity of catalase in kidneys of 
diabetic  WKY  and  diabetic  SHR.  Other  markers  of  oxidative  stress  such  as  MDA,  GSH,  and 
GSH/GSSG ratio remained unchanged in kidneys of diabetic WKY and diabetic SHR. The beneficial 
effects of honey supplementation on some of these markers were noticed in kidneys of diabetic WKY 
and diabetic SHR.  
Our results showed that TAS was significantly higher in control SHR compared to control WKY. 
Higher TAS is suggestive of lower oxidative stress. In some studies, TAS is reported to be lower in 
SHR  [48].  However,  another  study  found  no  significant  difference  in  TAS  between  SHR  and 
WKY [49].  In  our  study,  the  reason  for  the  increased  TAS  in  control  SHR  still  remains  unclear. 
Although TAS is supposed to reflect or indicate total antioxidant capacity, this is not always the case. 
TAS  assays  generally  measure  mainly  the  chain  breaking  antioxidants  such  as  urate,  ascorbate, 
bilirubin, α-tocopherol, carotenoids, and flavonoids, without taking into consideration the contribution 
of antioxidant enzymes and other metal binding proteins [50]. Urate, a weak antioxidant in vivo, is 
known to contribute more than 50% of total antioxidant activity in most TAS assays [50]. A study 
reported that patients suffering from renal failure had increased TAS as a result of elevated urate in 
spite of the fact that these patients had reduced ascorbate and other chain breaking antioxidants as well 
as increased free radical damage [51]. Consequently, it is recommended that TAS as an indicator of 
reduced oxidative stress should be interpreted cautiously because it may mislead and give a false 
impression of enhanced antioxidant status or defenses [50,51]. Accordingly, we do not believe that 
higher TAS in control SHR is indicative of reduced oxidative stress. The elevated BP in control SHR 
also lends credence to this view. The TAS results may corroborate previous findings as well as views 
expressed by other researchers that TAS, as a marker of oxidative stress, is not sufficient and thus Int. J. Mol. Sci. 2011, 12                       
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should be coupled with the measurements of antioxidant enzymes, individual antioxidants, and other 
markers of oxidative damage [50,51].  
Whether oxidative stress precedes hypertension or vice versa remains controversial. This is because 
there is evidence in support of either view [30,52]. Our results showed that the control SHR compared 
to control WKY had significantly increased CAT activity. Considering that SHR, compared to WKY, 
are known to exhibit increased oxidative stress [12,19,24,30], it is possible that the over-expressed 
activity of CAT might be a compensatory mechanism to protect the kidney against the deleterious 
effects of free radicals [43]. We are also of the view that the enhanced CAT activity might contribute 
considerably to the significantly reduced levels of MDA in control SHR. Surprisingly, the same rats 
(control SHR) also had significantly elevated BP. Normally, with the reduced levels of MDA, one 
would have inferred that the levels of oxidative stress were much lower in control SHR than in control 
WKY. However, it may not be scientifically sound to make such an inference in view of the elevated 
BP in control SHR coupled with the numerous evidences that support the role of oxidative stress in the 
development of hypertension  or vice versa [30,52]. In  fact,  it is  plausible  to  hypothesize that the 
reduced  levels  of  MDA  and  increased  TAS  in  control  SHR  might  be  consequences  of  enhanced 
CAT activity.  
3. Materials and Methods 
3.1. Animals 
This study complied with the institutional guidelines for the Care and Use of Animals for Scientific 
Purposes and was approved by the Animal Ethics Committee, Universiti Sains Malaysia [USM/Animal 
Ethics  Approval/2009/(46)  (145)].  Male  spontaneously  hypertensive  rats  (SHR)  and  Wistar-Kyoto 
(WKY) rats aged 12–14 weeks and weighing 250–300 g were used. The animals were obtained from 
the  Laboratory  Animal  Research  Unit  of  Universiti  Sains  Malaysia,  Health  Campus,  Kelantan, 
Malaysia. The rats were housed in polypropylene cages of one animal per cage. Standard pellet food 
and  water  were  provided  ad  libitum.  The  rats  were  kept  in  a  ventilated  animal  room  with  a  
12-h  dark/12  h-light  cycle  (lights  on  7.00  a.m.,  lights  off  7.00  p.m.)  and  controlled 
temperature (25 ±  2 ° C). 
3.2. Chemicals and Tualang Honey 
Streptozotocin  (STZ),  sodium  citrate  buffer  and  thiobarbituric  acid  were  obtained  from 
Sigma-Aldrich (St. Louis, MO, U.S.). Superoxide dismutase and glutathione peroxidase assay kits 
were purchased from Cayman (MI, U.S.). GSH:GSSG assay kit was purchased from Calbiochem (CA, 
U.S.). Bio-Rad protein assay kit was purchased from Bio-Rad (U.S.). All other chemicals used were of 
analytical grade obtained from commercial sources. 
Tualang honey (AgroMas®, Malaysia) was supplied by Federal Agricultural Marketing Authority 
(FAMA), Kedah, Malaysia. It has the following composition: total reducing sugar (67.5%) [fructose 
(29.6%), glucose (30.0%), maltose (7.9%); fructose/glucose ratio (0.99)], sucrose (0.6%) and water 
(20.0%). Tualang honey was freshly diluted with distilled water just before administration. The daily 
dose of tualang honey (1.0 g/kg body weight) was chosen based on the findings from our preliminary Int. J. Mol. Sci. 2011, 12                       
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study [16]. Our subsequent studies have also confirmed this dose to be effective and devoid of any 
detectable adverse events in pancreas and kidney of diabetic and non-diabetic rats [17,18].  
3.3. Induction of Diabetes and Treatment 
Experimental diabetes was induced in SHR and normotensive WKY rats (250–300 g) by a single 
intraperitoneal injection of STZ (60 mg/kg body weight; dissolved in sodium citrate buffer, pH 4.5) 
after an overnight fast (at least 16 hours). Control groups (non-diabetic SHR and WKY rats) received 
only sodium citrate buffer without STZ. Forty-eight hours after the administration of STZ or citrate 
buffer, fasting blood glucose concentrations were measured with a portable glucometer (Accu-Chek, 
Roche,  Germany)  using  a  drop  of  blood  from  the  tail  vein.  Rats  with  fasting  blood  glucose 
level  12.0 mmol/L were considered diabetic and included in the study. Diabetic and non-diabetic 
SHR and WKY rats were randomly assigned to groups of five to seven rats. With the aid of oral 
gavage, once each morning, the rats were treated with distilled water or tualang honey for three weeks 
as shown in Table 1. 
Table 1. Treatment groups. 
  Group Treatment 
  Non-diabetic WKY Distilled water (0.5 mL) 
  Diabetic WKY Distilled water (0.5 mL)  
Diabetic WKY Tualang honey (1.0 g/kg/body weight) 
  Non-diabetic SHR Distilled water (0.5 mL) 
  Diabetic SHR Distilled water (0.5 mL)  
Diabetic SHR Tualang honey (1.0 g/kg/body weight) 
3.4. Measurement of Blood Pressure, Blood Glucose and Body Weight  
Systolic blood pressure, blood glucose and body weight were measured before commencement of 
treatment and at the end of the treatment period. Systolic blood pressure was measured in conscious 
rats by a tail-cuff plethysmographic non-invasive method (Model 179, Life Science, U.S.). At least 
four consecutive measurements were recorded and the average was calculated. Fasting blood glucose 
concentrations were measured using a glucometer (Accu-Chek, Roche, Germany). The body weight 
was measured with the aid of a weighing balance. After treatment for 3 weeks, the animals were fasted 
for at least 16 hours and sacrificed by decapitation.  
3.5. Processing of Tissues and Biochemical Assays  
The left kidney was rapidly excised, washed in ice-cold normal saline, blotted and quickly stored at 
−80 ° C until use. 10% (w/v) homogenate of kidney was prepared in Tris-HCl (0.1 M, pH 7.4) using an 
ice-chilled glass homogenizing vessel in a homogenizer fitted with Teflon pestle (Glas-Col, U.S.) at 
900 rpm. The suspended mixture was centrifuged at 1000 ×  g for 10 min at 4 ° C in a refrigerated 
centrifuge. The resulting supernatant was used for the assay of total protein, activities of antioxidant 
enzymes and other markers of oxidative stress. Int. J. Mol. Sci. 2011, 12                       
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3.6. Superoxide Dismutase (SOD) Assay 
SOD activity was determined using Cayman assay kit according to manufacturer’s instruction. This 
assay kit utilizes a tetrazolium salt for the detection of superoxide radicals generated by xanthine 
oxidase and hypoxanthine. One unit of SOD is defined as the amount of enzyme needed to exhibit 
50% dismutation of superoxide radical. The SOD assay measures all the three types of SOD (Cu/Zn, 
Mn, and FeSOD). 
3.7. Catalase (CAT) Assay 
CAT activity was measured according to the method of Goth [53]. Briefly, this assay involves the 
incubation  of  sample  test  tube  containing  0.5  mL  of  hydrogen  peroxide  and  0.1  mL  of  kidney 
homogenate. After incubation at 37 ° C for 60 seconds, the enzymatic reaction was stopped by addition 
of 0.5 mL of a Mmonium molybdate solution. The yellow complex of ammonium molybdate and 
hydrogen  peroxide  was  then  measured  spectrophotometrically  at  405  nm.  One  unit  of  CAT  was 
defined as the amount of enzyme that catalyzes the decomposition of 1 µmol of hydrogen peroxide 
per minute.  
3.8. Glutathione Peroxidase (GPx) Assay 
GPx activity was measured using Cayman assay kits according to manufacturer’s instructions. This 
kit measures GPx activity indirectly by a coupled reaction with glutathione reductase (GR). Oxidized 
glutathione (GSSG), produced upon reduction of hydroperoxide by GPx, is recycled to its reduced 
state by GR and NADPH. The oxidation of NADPH is accompanied by a decrease in absorbance at 
340 nm. One unit of GPx is defined as the amount of enzyme that catalyzes the oxidation of 1 nmol of 
NADPH per minute at 25 C. 
3.9. Glutathione-S-Transferase (GST) Assay 
GST activity was assayed according to the method of Habig et al [54]. Briefly, 2 mL of 0.3 M 
potassium phosphate buffer (pH 6.35), 75 µL  of 30 mM CDNB solution, 725 µL  of distilled water and 
0.1 mL of kidney homogenate were pipetted into a test tube. The test tube was vortexed and incubated 
at 37 ° C for 10 minutes. After incubation, the reaction was initiated by addition of 100 µL  of 30 mM 
reduced  glutathione  solution.  The  decrease  in  absorbance  was  measured  spectrophotometrically  at 
340 nm and recorded every 30 seconds for 4 minutes. One unit of GST was defined as the amount of 
enzyme that catalyzes the conjugation of 1 nmol of GSH-CDNB per minute. 
3.10. Glutathione Reductase (GR) Assay 
GR activity was assayed according to the method of Goldberg and Spooner [55]. Briefly, 1 mL of 
2.728 mM GSSG solution and 40 µL  of kidney homogenate were incubated for 5 minutes at 37 ° C. 
After incubation, the reaction was initiated by addition of 200 µL  of 1.054 mM NADPH solution. The 
decrease in absorbance was measured at 340 nm using a spectrophotometer (Unico UV-2800, China) 
and recorded every 30 seconds over a period of 5 minutes. One unit of GR was defined as the amount Int. J. Mol. Sci. 2011, 12                       
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of enzyme that catalyzes the oxidation of 1 nmol of NADPH per minute. One unit of GR was defined 
as the amount of enzyme that catalyzes the oxidation of 1 nmol of NADPH per minute.  
3.11. Total Antioxidant Status (TAS) Assay 
TAS was measured according to the method of Koracevic et al. [56]. 10 µL  of kidney homogenate 
was pipetted in a test tube containing 0.49 mL of 100 mM sodium phosphate buffer. This was followed 
by the addition of 0.5 mL of 10 mM sodium benzoate solution, 0.2 mL of Fe-EDTA mixture and 
0.2 mL  of  10  mM  H202  solution.  Negative  control  (with  phosphate  buffer  instead  of  the  kidney 
homogenate) containing similar reagents as in sample test tubes was also prepared. The test tubes were 
vortexed and incubated at 37 ° C for 60 minutes. This was followed by the addition of 1 mL of 20% 
acetic acid and 0.8% (w/v) thiobarbituric acid (TBA). The reaction tubes were incubated at 100 ° C for 
10  minutes.  After  cooling  to  room  temperature,  the  absorbance  of  the  mixture  was  measured 
spectrophotometrically  at  532  nm  against  distilled  water.  TAS  in  the  kidney  homogenates  was 
calculated using uric acid as standard. TAS was expressed as nmol uric acid equivalent per mg protein.  
3.12. Lipid Peroxidation Assay 
Lipid  peroxidation  was  determined  as  malondialdehyde  (MDA)  according  to  the  method  of  
Ohkawa et al. [57]. For this, 100 µL  of kidney homogenates or MDA standards were pipetted into test 
tubes containing 1.5 mL of 20% (w/v) glacial acetic acid (pH 3.5), 200 µL  of 8.1% (w/v) sodium 
dodecyl sulphate (SDS), 1.5 mL of 0.8% (w/v) TBA and 700 µL  of distilled water. After incubation at 
95 ° C for 60 minutes, the test tubes were cooled and then centrifuged at 3000 ×  g for 10 minutes. The 
MDA concentration was measured at 532 nm using a spectrophotometer (Unico UV-2800, China).  
1,1,3,3-Tetraethoxypropane (TEP) was used as MDA standard. The MDA concentration was expressed 
as nmol MDA per mg protein. 
3.13. Assay of Reduced and Oxidized Glutathione  
Total glutathione and oxidized glutathione (GSSG) were estimated using GSH:GSSG ratio assay kit 
(Calbiochem, CA, U.S.) according to the manufacturer's instructions. Reduced glutathione (GSH) and 
GSH/GSSG ratio were then calculated. Briefly, the kidney homogenates were deproteinized in 5% 
metaphosphoric acid, centrifuged and the supernatants were used for the estimation of glutathione. For 
GSSG  assay,  the kidney homogenates  were  immediately mixed  with  the thiol-scavenging
  reagent,  
1-methy-2-vinylpyridinium  trifluoromethanesulfonate  to  derivatize  GSH.  Samples  were  mixed 
sequentially  with  the  chromogen  5,5’-dithiobis-2-nitrobenzoic  acid,  glutathione  reductase  and
 
NADPH.  The  absorbance  of  each  sample  was  recorded  at  412  nm  and  the
  reaction  rate  was 
determined. A standard curve was constructed
 using a known quantity of GSH standards. GSH and 
GSSG concentrations were
 calculated by linear regression against the standard curve. GSH/GSSG ratio 
was calculated using the formula [ratio = (GSH − 2GSSG)/GSSG]. GSH and GSSG concentrations 
were expressed as nmol of glutathione per mg protein. Int. J. Mol. Sci. 2011, 12                       
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3.14. Protein Assay 
Protein  concentration  was  estimated  using  Bio-Rad  protein  assay  kit  based  on  the  method  of 
Bradford [58]. The assay is a dye-binding assay in which a differential color change of a dye, with 
maximum absorbance at 595 nm, occurs in response to various concentrations of protein. A standard 
curve was obtained using bovine serum albumin. 
3.15. Statistical Analysis 
Statistical analysis was carried out using SPSS 18.0.1. Data were analyzed using independent t test 
to  identify  significance  of  difference  between  two  groups.  Data  are  expressed  as  mean  ±   SEM.  
P value < 0.05 was considered to be statistically significant.  
4. Conclusions  
If  hyperglycemia  is  not  a  prerequisite  for  the  development  of  high  blood  pressure  in  diabetic 
normotensive rats [35], then oxidative stress in diabetic normotensive rats may be a consequence of 
hypertension and/or diabetes. Furthermore, our data seem to suggest that oxidative stress, unlike in 
SHR, may not contribute considerably to elevated blood pressure in STZ-treated diabetic rats. Though 
additional studies with other potent antioxidants such as tempol are required, the inability of tualang 
honey to decrease elevated BP of diabetic WKY further substantiates this view. The effectiveness of 
antioxidants including tualang honey not only in ameliorating oxidative stress but also in reducing 
elevated BP in diabetic SHR corroborate the prominent role of ROS in elevated BP of SHR. Our 
results  indicate  that  differences  in  types,  severity,  and  combinations/complications  of  diseases 
(hypertension and/or diabetes), as well as strains, may influence antioxidant enzymes in response to 
changes  in  redox  status.  Our  study  underscores  the  need  for  additional  studies  to  elucidate  the 
mechanisms  by  which  STZ-induced  diabetes  causes  hypertension  in  diabetic  normotensive  rats. 
Further  studies  that  investigate  the  protein  and  gene  expressions  of  GPx  and  GR  may  reveal  a 
differential role in regulating post-translational modification of these antioxidant enzymes in diabetic 
WKY and diabetic SHR.  
Acknowledgements 
This work was supported by a grant (RU:1001/PPSP/81202020) from Universiti Sains Malaysia 
(USM). We acknowledge USM Fellowship. We also express our appreciation to Federal Agricultural 
Marketing Authority (FAMA), Kedah, Malaysia for supplying tualang honey. 
References 
1.  Kannel, W.B.; McGee, D.L. Diabetes and cardiovascular disease: The Framingham study. JAMA 
1978, 241, 2035–2038. 
2.  Christlieb, A.R. Diabetes and hypertensive vascular disease. Am. J. Cardiol. 1973, 32, 592–606. Int. J. Mol. Sci. 2011, 12                       
 
 
1904 
3.  Fein, F.S.; Capasso, J.M.; Aronson, R.S.; Cho, S.; Nordin, C.; Miller-Green, B.; Sonnenblick, E.H.; 
Factor, S.M. Combined renovascular hypertension and diabetes in rats: A new preparation of 
congestive cardiomyopathy. Circulation 1984, 70, 318–330. 
4.  Ross, R. The pathogenesis of atherosclerosis. N. Engl. J. Med. 1986, 314, 488–500. 
5.  Reaven, G.M. Pathophysiology of insulin resistance in human disease. Physiol. Rev. 1995, 75, 
473–486. 
6.  Pieper, G.M.; Gross, G.J. Oxygen-derived free radicals abolish endothelium-dependent relaxation 
in diabetic rat aorta. Am. J. Physiol. 1988, 255, H825–H833. 
7.  Tesfamariam,  B.;  Cohen,  R.A.  Free  radicals  mediate  endothelial  cell  dysfunction  caused  by 
elevated glucose. Am. J. Physiol. 1992, 263, H321–H326. 
8.  Ohara, Y.; Petersen, T.E.; Harrison, D.G. Hypercholesterolemia increases endothelial O2
− anion 
production. J. Clin. Invest. 1993, 91, 2546–2551.  
9.  Marui, N.; Offerman, M.K.; Swerlick, R.; Kunsch, C.; Rosen, C.A.; Ahmad, M.; Alexander, R.W.; 
Medford, R.M. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression 
are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells.  
J. Clin. Invest. 1993, 92, 1866–1874. 
10.  Laight, D.W.; Desai, K.M.; Anggard, E.E.; Carrier, M.J. Endothelial dysfunction accompanies a 
pro-oxidant,  pro-diabetic  challenge  in  the  insulin  resistant,  obese  Zucker  rat  in  vivo.  Eur.  J. 
Pharmacol. 2000, 402, 95–99. 
11.  Weber,  C.;  Erl,  W.;  Pietsch,  A.;  Strobel,  M.;  Ziegler-Heitbrock,  H.W.L.;  Weber,  P.C. 
Antioxidants  inhibit  monocyte  adhesion  by  suppressing  nuclear  factor-κB  mobilization  and 
induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals. 
Arterioscler. Thromb. 1994, 14, 1665–1673. 
12.  Friedman, J.; Peleg, E.; Kagan, T.; Shnizer, S.; Rosenthal, T. Oxidative stress in hypertensive, 
diabetic, and diabetic hypertensive rats. Am. J. Hypertens. 2003, 16, 1049–1052. 
13.  Tan, H.T.; Rahman, R.A.; Gan, S.H.; Halim, A.S.; Hassan, S.A.; Sulaiman, S.A.; Kirnpal-Kaur, B. 
The  antibacterial  properties  of  Malaysian  tualang  honey  against  wound  and  enteric 
microorganisms in comparison to manuka honey. BMC Complement. Altern. Med. 2009, 9, 1–8. 
14.  Ghashm, A.A.; Othman, N.H.; Khattak, M.N.; Ismail, N.M.; Saini, R. Antiproliferative effect of 
tualang honey on oral squamous cell carcinoma and osteosarcoma cell lines. BMC Complement. 
Altern. Med. 2010, 10, 49. 
15.  Mohamed, M.; Sirajudeen, K.N.S.; Swamy, M.; Yaacob, N.S.; Sulaiman, S.A. Studies on the 
antioxidant properties of tualang honey of Malaysia. Afr. J. Trad. CAM 2010, 7, 59–63. 
16.  Erejuwa, O.O.; Gurtu, S.; Sulaiman, S.A.; Ab Wahab, M.S.; Sirajudeen, K.N.S.; Salleh, M.S. 
Hypoglycemic  and  antioxidant  effects  of  honey  supplementation  in  streptozotocin-induced 
diabetic rats. Int. J. Vitam. Nutr. Res. 2010, 80, 74–82. 
17.  Erejuwa, O.O.; Sulaiman, S.A.; Ab Wahab, M.S.; Sirajudeen, K.N.S.; Salzihan, M.S.; Gurtu, S. 
Antioxidant  protective  effect  of  glibenclamide  and  metformin  in  combination  with  honey  in 
pancreas of streptozotocin-induced diabetic rats. Int. J. Mol. Sci. 2010, 11, 2056–2066. 
18.  Erejuwa, O.O.; Sulaiman, S.A.; Ab Wahab, M.S.; Sirajudeen, K.N.S.; Salzihan, M.S.; Gurtu, S. 
Comparison of antioxidant effects of honey, glibenclamide, metformin, and their combinations in 
kidney of streptozotocin-induced diabetic rats. Int. J. Mol. Sci. 2011, 12, 829–843. Int. J. Mol. Sci. 2011, 12                       
 
 
1905 
19.  Trippodo, N.C.; Frolich, E.D. The genetically hypertensive rat as a model for human essential 
hypertension. Circ. Res. 1981, 48, 309–319. 
20.  Rakieten, N.; Rakieten, M.L.; Nadkarni, M.V. Studies on the diabetogenic action of streptozotocin 
(NSC-37917). Cancer Chemother. Rep. 1963, 29, 91–98.  
21.  Davidoff,  A.J.;  Pinault,  F.M.;  Rodgers,  R.L.  Ventricular  relaxation  of  diabetic  spontaneously 
hypertensive rats. Hypertension 1990, 15, 643–651. 
22.  Erejuwa, O.O.; Sulaiman, S.A.; Ab Wahab, M.S.; Sirajudeen, K.N.S.; Salzihan, M.S.; Gurtu, S. 
Universiti Sains Malaysia, Kubang Kerian, Kelantan. Unpublished work, 2010. 
23.  Roos,  M.D.;  Wen,  X.;  Kaihong,  S.;  Clark,  J.A.;  Xiaoyong,  Y.;  Chin,  E.;  Paterson,  A.J.;  
Kudlow, J.E. Streptozotocin, an analog of N-acetylglucosamine, blocks the removal of O-GlcNAc 
from intracellular proteins. Proc. Assoc. Am. Phys. 1998, 110, 1–11. 
24.  Suzuki, H.; Swei, A.; Zweifach, B.W.; Schmid-Schonbein, G.W. In vivo evidence for microvascular 
oxidative  stress  in  spontaneously  hypertensive  rats:  Hydroethidine  microfluorography. 
Hypertension 1995, 25, 1083–1089. 
25.  Haluzik, M.; Nedvidkova, J. The role of nitric oxide in the development of streptozotocin-induced 
diabetes mellitus: experimental and clinical implication. Physiol. Res. 2000, 49, 37–42. 
26.  Takasu, N.; Komiya, I.; Asawa, T.; Nagasawa, Y.; Yamada, T. Streptozotocin- and alloxan-induced 
H2O2  generation  and  DNA  fragmentation  in  pancreatic  islets.  H2O2  as  mediator  for  DNA 
fragmentation. Diabetes 1991, 40, 1141–1145. 
27.  Pamela, C.C.; Richard, A.H. Biochemistry; J.B. Lippincott Co.: Philadelphia, PA, USA, 1994, 
pp. 269–280. 
28.  Stearns, S.B.; Tepperman, H.M.; Tepperman, J. Studies on the utilization and mobilization of 
lipid in skeletal muscles from streptozotocin-diabetic and control rats. J. Lipid Res. 1979, 20, 
654–662. 
29.  Factor,  S.M.;  Bhan,  R.;  Minase,  T.;  Wolinsky.  H.;  Sonnenblick,  E.H.  Hypertensive-diabetic 
cardiomyopathy in the rat. An experimental model of human disease. Am. J. Pathol. 1981, 102, 
219–228. 
30.  Touyz,  R.M.;  Schiffrin,  E.L.  Oxidative  stress  in  arterial  hypertension:  oxidative  stress  and 
hypertension.  In  Atherosclerosis  and  Oxidant  Stress—A  New  Perspective;  Holtzman,  J.,  Ed.; 
Springer: New York, NY, USA, 2008; pp. 51–78. 
31.  Bunag, R.D.; Tomita, T.; Sasaki, S. Streptozotocin diabetic rats are hypertensive despite reduced 
hypothalamic responsiveness. Hypertension 1982, 4, 556–565. 
32.  Sharma, J.N.; Kesavarao, U. Cardiac kallikrein in hypertensive and normotensive rats with and 
without diabetes. Immunopharmacology 1996, 33, 341–343. 
33.  To  mLinson,  K.C.;  Gardiner,  S.M.;  Bennett,  T.  Blood  pressure  in  streptozotocin-treated 
Brattleboro and Long Evans rats. Am. J. Physiol. 1990, 258, R852–R859. 
34.  Rodgers,  R.L.  Depressor  effect  of  diabetes  in  the  spontaneously  hypertensive  rat:  Associated 
changes in heart performance. Can. J. Physiol. Pharmacol. 1986, 64, 1177–1184. 
35.  Kawashima,  H.;  Igarashi,  T.;  Nakajima,  Y.;  Akiyama,  Y.;  Usuki,  K.;  Ohtake,  S.  Chronic 
hypertension induced by streptozotocin in rats. Naunyn-Schmiedebergs Arch. Pharmacol. 1978, 
305, 123–126. Int. J. Mol. Sci. 2011, 12                       
 
 
1906 
36.  Susic,  D.;  Mandal,  A.K.;  Jovovic,  D.J.;  Radujkovic,  G.;  Kentera,  D.  Streptozotocin-induced 
diabetes mellitus lowers blood pressure in spontaneously hypertensive rat. Clin. Exp. Hypertens. A 
1990, 12, 1021–1035. 
37.  Kelly, D.J.; Wilkinson-Berka, J.L.; Allen, T.J.; Cooper, M.E.; Skinner, S.L. A new model of 
diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR). 
Kidney Int. 1998, 54, 343–352. 
38.  Davidoff,  A.J.;  Rodgers,  R.L.  Insulin,  thyroid  hormone,  and  heart  function  of  diabetic 
spontaneously hypertensive rat. Hypertension 1990, 15, 633–642. 
39.  Medeiros,  F.J.;  Aguila,  M.B.;  Mandarim-de-Lacerda,  C.A.  Renal  cortex  remodeling  in 
streptozotocin-induced diabetic spontaneously hypertensive rats treated with olive oil, palm oil 
and fish oil from Menhaden. Prostaglandins Leukot. Essent. Fatty Acids 2006, 75, 357–365. 
40.  Moreno,  J.J.;  Carbonell,  T.;  Sá nchez,  T.;  Miret,  S.;  Mitjavila,  M.T.  Olive  oil  decreases  both 
oxidative stress and the production of arachidonic acid metabolites by the prostaglandin G/H 
synthase pathway in rat macrophages1. J. Nutr. 2001, 131, 2145–2149. 
41.  Nyby, M.D.; Abedi, K.; Eslami, P.; Hernandez, G.; Smutko, V.; Berger, M.E.; Tuck, M.L. Dietary 
fish  oil  prevents  hypertension,  oxidative  stress  and  suppression  of  endothelial  nitric  oxide 
synthase expression in fructose-fed rats. Am. J. Hypertens. 2004, 17, 216. 
42.  Ge, X.; Yu, Q.; Qi, W.; Shi, X.; Zhai, Q. Chronic insulin treatment causes insulin resistance in 
3T3-L1 adipocytes through oxidative stress. Free Radic. Res. 2008, 42, 582–591. 
43.  Tiedge, M.; Lortz, S.; Munday, R.; Lenzen, S. Protection against the co-operative toxicity of nitric 
oxide  and  oxygen  free  radicals  by  over-expression  of  antioxidant  enzymes  in  bioengineered 
insulin-producing RI nm5F cells. Diabetologia 1999, 42, 849–855. 
44.  Wolff, S.P.; Dean, R.T.  Glucose autoxidation and  protein  modification:  The potential role of 
autoxidative glycosylation in diabetes. Biochem. J. 1987, 245, 243–250. 
45.  Pigeolet, E.; Corbisier, P.; Houbion, A.; Lambert, D.; Michiels, C.; Raes, M.; Zachary, M.D.; 
Remacle, J. Glutathione peroxidase, superoxide dismutase and catalase inactivation by peroxides 
and oxygen derived free radicals. Mech. Ageing Dev. 1990, 51, 283–297. 
46.  Sartori-Valinotti, J.C.; Iliescu, R.; Fortepiani, L.; Yanes, L.; Reckelhoff, J. Sex differences in 
oxidative stress and the impact on blood pressure control and cardiovascular disease. Clin. Exp. 
Pharm. Physiol. 2007, 34, 938–945. 
47.  Maritim, A.C.; Sanders, R.A.; Watkins, J.B. Diabetes, oxidative stress and antioxidants: A review. 
J. Biochem. Mol. Toxicol. 2003, 17, 24–38. 
48.  Newaz, M.A.; Nawal, N.N. Effect of alpha-tocopherol on lipid peroxidation and total antioxidant 
status in spontaneously hypertensive rats. Am. J. Hypertens. 1998, 11, 1480–1485. 
49.  Mantle,  D.;  Patel,  V.B.;  Why,  H.J.;  Ahmed,  S.;  Rahman,  I.;  MacNee,  W.;  Wassif,  W.S.; 
Richardson,  P.J.;  Preedy,  V.R.  Effects  of  lisinopril  and  a  mLodipine  on  antioxidant  status in 
experimental hypertension. Clin. Chim. Acta 2000, 299, 1–10. 
50.  Young, I.S. Measurement of total antioxidant capacity. J. Clin. Pathol. 2001, 54, 339–340. 
51.  Jackson,  P.;  Loughrey,  C.M.;  Lightbody,  J.H.;  McNamee,  P.T.;  Young,  I.S.  Effect  of 
hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal 
failure. Clin. Chem. 1995, 41, 1135–1138. Int. J. Mol. Sci. 2011, 12                       
 
 
1907 
52.  Nabha, L.; Garbern, J.C.; Buller, C.L.; Charpie, J.R. Vascular oxidative stress precedes high blood 
pressure in spontaneously hypertensive rats. Clin. Exp. Hypertens. 2005, 27, 71–82. 
53.  Gott, L. A simple method for determination of serum catalase activity and revision of reference 
range. Clin. Chim. Acta 1991, 196, 143–151. 
54.  Habig, W.H.; Pabst, M.J.; Jakoby, W.B. Glutathione-S-transferases. The first enzymatic step in 
mercapturic acid formation. J. Biol. Chem. 1974, 249, 7130–7139. 
55.  Goldberg, D.M.; Spooner, R.J. Assay of glutathione reductase. In Methods of Enzymatic Analysis; 
Bergmeyen, H.V., Ed.; Verlag Chemie: Weinheim, Germany, 1983; pp. 258–265. 
56.  Koracevic,  D.;  Koracevic,  G.;  Djordjevic,  V.;  Andrejevic,  S.;  Cosic,  V.  Method  for  the 
measurement of antioxidant activity in human fluids. J. Clin. Pathol. 2000, 54, 356–361. 
57.  Ohkawa, H.; Ohishi, N.; Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric 
acid reaction. Anal. Biochem. 1979, 95, 351–358. 
58.  Bradford,  M.A.  Rapid  and  sensitive  method  for  the  quantitation  of  microgram  quantities  of 
protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248–254. 
©  2011  by  the  authors;  licensee MDPI,  Basel,  Switzerland.  This  article  is  an  open  access  article 
distributed  under  the  terms  and  conditions  of  the  Creative  Commons  Attribution  license 
(http://creativecommons.org/licenses/by/3.0/). 